We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
Indian drugmaker Cadila Healthcare Ltd. will potentially ramp up vaccine capacity to 240 million annual doses. The drugmaker expects regulatory approval for its shot by June.
